Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Interictal Scalp Electroencephalography and Intraoperative Electrocorticography in Magnetic Resonance Imaging–Negative Temporal Lobe Epilepsy Surgery
Burkholder, David B. , Šulc, Vlastimil , Hoffman, E. Matthew , Cascino, Gregory D. , So, Elson L., Marsh, W. Richard , Meyer, Fredric B. , Wass, C. Thomas, Watson, Robert E. , Van Gompel, Jamie J, Britton, Jeffrey W. , Gompel, Jamie J. Van , Giannini, Caterina , Worrell, Gregory A. , Burkholder, David B

JAMA Neurology | April 28, 2014 | Volume: 71 | Issue: 6 | Pages: 702

10.1001/jamaneurol.2014.585 | PMID 24781216 Get It

Recurrence of autoimmune hepatitis, primary biliary cirrhosis, and primary sclerosing cholangitis after transplantation
Harnois, Denise M. , Yataco, Maria, Nakhleh, Raouf E. , Yataco, Maria L

Clinical Liver Disease | April 28, 2014 | Volume: 3 | Issue: 4 | Pages: 90-92

10.1002/cld.341 | PMID 30992894 Get It

Kynurenic Acid Levels in Cerebrospinal Fluid from Patients with Alzheimer's Disease or Dementia with Lewy Bodies
Nielsen, Henrietta M. , Orhan, Funda , Londos, Elisabet , Minthon, Lennart, Erhardt, Sophie , Wennström, Malin , Erhardt, Sopie

International Journal of Tryptophan Research | April 28, 2014 | Volume: 7 | Issue: No issue available | Pages: No page available

10.4137/ijtr.s13958 | PMID 24855376 Get It

Kynurenic acid (KYNA) is implicated in cognitive functions. Altered concentrations of the compound are found in serum and cerebrospinal fluid (CSF) of patients with Alzheimer's disease (AD). Further studies to determine whether KYNA serves as a biomarker for cognitive decline and dementia progression are required. In this study, we measured CSF KYNA levels in AD patients (n = 19), patients with dementia with Lewy bodies (DLB) (n = 18), and healthy age-matched controls (Ctrls)) (n = 20) to further explore possible correlations between KYNA levels, cognitive decline, and well-established AD and inflammatory markers. Neither DLB patients nor AD patients showed significantly altered CSF KYNA levels compared to Ctrls. However, female AD patients displayed significantly higher KYNA levels compared to male AD patients, a gender difference not seen in the Ctrl or DLB group. Levels of KYNA significantly correlated with the AD-biomarker P-tau and the inflammation marker soluble intercellular adhesion molecule-1 (sICAM-1) in the AD patient group. No associations between KYNA and cognitive functions were found. Our study shows that, although KYNA was not associated with cognitive decline in AD or DLB patients, it may be implicated in AD-related hyperphosphorylation of tau and inflammation. Further studies on larger patient cohorts are required to understand the potential role of KYNA in AD and DLB.
Emotion Talk and Friend Responses Among Early Adolescent Same‐sex Friend Dyads
Legerski, John‐Paul , Biggs, Bridget K. , Greenhoot, Andrea Follmer , Sampilo, Marilyn L., Biggs, Bridget K

Social Development | April 28, 2014 | Volume: 24 | Issue: 1 | Pages: 20-38

10.1111/sode.12079 Get It

AbstractTo better understand early adolescent emotion talk within close same‐sex friendships, this observational study examined emotion talk, as measured by emotion term use, in relation to friend supportive and dismissive responses to such terms among 116 adolescents (58 friend dyads) in Grades 7–8 (56.9% female, M = 13.08, SD = .61). Partial intra‐class correlation coefficients derived by using actor partner interdependence models revealed similarities in the frequency of dyad mates use of positive and negative emotions terms. Chi‐square analyses indicated that when friends responded to participants' emotion talk supportively, rather than dismissively, participants were more likely to disclose emotions in subsequent utterances. Research and clinical implications for early adolescent emotional development are discussed.
Genetic Profiling by Single‐Nucleotide Polymorphism‐Based Array Analysis Defines Three Distinct Subtypes of Orbital Meningioma
Ho, Cheng‐Ying , Mosier, Stacy, Safneck, Janice R., Salomão, Diva R. , Miller, Neil R. , Gocke, Christopher D. , Batista, Denise , Eberhart, Charles G. , Rodríguez, Fausto J.

Brain Pathology | April 28, 2014 | Volume: 25 | Issue: 2 | Pages: 193-201

10.1111/bpa.12150 | PMID 24773246 Get It

AbstractOrbital meningiomas can be classified as primary optic nerve sheath (ON) meningiomas, primary intraorbital ectopic (Ob) meningiomas and spheno‐orbital (Sph‐Ob) meningiomas based on anatomic site. Single‐nucleotide polymorphism (SNP)‐based array analysis with the Illumina 300K platform was performed on formalin‐fixed, paraffin‐embedded tissue from 19 orbital meningiomas (5 ON, 4 Ob and 10 Sph‐Ob meningiomas). Tumors were World Health Organization (WHO) grade I except for two grade II meningiomas, and one was NF2‐associated. We found genomic alterations in 68% (13 of 19) of orbital meningiomas. Sph‐Ob tumors frequently exhibited monosomy 22/22q loss (70%; 7/10) and deletion of chromosome 1p, 6q and 19p (50% each; 5/10). Among genetic alterations, loss of chromosome 1p and 6q were more frequent in clinically progressive tumors. Chromosome 22q loss also was detected in the majority of Ob meningiomas (75%; 3/4) but was infrequent in ON meningiomas (20%; 1/5). In general, Ob tumors had fewer chromosome alterations than Sph‐Ob and ON tumors. Unlike Sph‐Ob meningiomas, most of the Ob and ON meningiomas did not progress even after incomplete excision, although follow‐up was limited in some cases. Our study suggests that ON, Ob and Sph‐Ob meningiomas are three molecularly distinct entities. Our results also suggest that molecular subclassification may have prognostic implications.
Contraception and Hormonal Management in the Perimenopause
Long, Margaret E. , MacLaughlin, Kathy L. , Pruthi, Sandhya , Casey, Petra M., Faubion, Stephanie S.

Journal of Women's Health | April 28, 2014 | Volume: 24 | Issue: 1 | Pages: 3-10

10.1089/jwh.2013.4544 | PMID 24773233 Get It

Homicidal/violent thoughts, suicidal ideation and violent behavior in adolescents with social phobia in Metropolitan Lima, Perú
Vivar, Roxana, Morón, Giannina, Lay, Martín Padilla , Alarcón, Renato D.

Asia-Pacific Psychiatry | April 28, 2014 | Volume: 6 | Issue: 3 | Pages: 252-258

10.1111/appy.12129 | PMID 24771716 Get It

The Risk of Endoscopic Mucosal Resection in the Setting of Clopidogrel Use
Namasivayam, Vikneswaran , Prasad, Ganapathy A., Lutzke, Lori S., Dunagan, Kelly T., Borkenhagen, Lynn S., Okoro, Ngozi I., Tomizawa, Yutaka , Buttar, Navtej , Michel, Wongkeesong Louis, Wang, Kenneth K. , Buttar, Navtej S, Tomizawa, Yutaka

ISRN Gastroenterology | April 27, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-5

10.1155/2014/494157 | PMID 24944824 Get It

Objective. Guidelines on antiplatelet medication use during endoscopy are based on limited evidence. We investigate the risk of bleeding and ischemic events in patients undergoing endoscopic mucosal resection (EMR) of esophageal lesions in the setting of scheduled cessation and prompt resumption of clopidogrel. Design. Single centre retrospective review. Patients. Patients undergoing EMR of esophageal lesions. Interventions. Use of clopidogrel before EMR and resumption after EMR. Patients cease antiplatelets and anticoagulants 7 days before EMR and resume clopidogrel 2 days after EMR in average risk patients. Main Outcomes. Gastrointestinal bleeding (GIB) and ischemic events (IE) within 30 days of EMR. Results. 798 patients underwent 1716 EMR. 776 EMR were performed on patients on at least 1 antiplatelet/anticoagulant (APAC). 17 EMR were performed following clopidogrel cessation. There were 14 GIB and 2 IE. GIB risk in the setting of recent clopidogrel alone (0%) was comparable to those not on APAC (1.1%) (P=1.0). IE risk on clopidogrel (6.3%) was higher than those not on APAC (0.1%) (P=0.03). Limitations. Retrospective study. Conclusions. Temporary cessation of clopidogrel before EMR and prompt resumption is not associated with an increased risk of gastrointestinal bleeding but may be associated with increased ischemic events.
Mucormycosis in Patients with Inflammatory Bowel Disease: Case Series and Review of the Literature
Abidi, Maheen Z. , Weiland, Tim, Dyken, Irminne Van, Tande, Aaron J. , Tosh, Pritish K. , Walker, Randall C., Coelho-Prabhu, Nayantara , Tande, Aaron , Cummins, Nathan W. , Coelho–Prabhu, Nayantara , Hargreaves, James , Abidi, Maheen Z , Abidi, Maheen Z

Case Reports in Medicine | April 27, 2014 | Volume: 2014 | Issue: No issue available | Pages: 1-7

10.1155/2014/637492 | PMID 24872818 Get It

Mucormycosis is a rare and often fatal invasive fungal infection mostly seen in immune-compromised individuals. A high index of clinical suspicion is necessary, so that effective preemptive therapy can be started, as timely intervention is crucial. In this series we present three cases of invasive mucormycosis in patients with underlying inflammatory bowel disease that had received therapy with immunomodulators prior to the infection. All three had varied clinical manifestations. We also review the literature of invasive mucormycosis in patients with inflammatory bowel disease.